BioMarin Pharmaceutical Inc. logo BMRN - BioMarin Pharmaceutical Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 29
HOLD 12
SELL 0
STRONG
SELL
0
| PRICE TARGET: $91.81 DETAILS
HIGH: $124.00
LOW: $59.00
MEDIAN: $97.50
CONSENSUS: $91.81
UPSIDE: 37.65%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

C+ 59.7 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

Profitability

Weight: 25%
C- 47.7
  • 5yr Avg ROIC 3.1% 25/100
  • Operating Margin Trend +5.13 pp/yr 100/100
Contributes 11.9 pts toward composite.

Capital Efficiency

Weight: 15%
D 37.0
  • 5yr Avg ROE 3.6% 28/100
  • 5yr Share-Count CAGR 0.6% 53/100
Contributes 5.5 pts toward composite.

Growth Quality

Weight: 25%
C 53.8
  • 5yr Revenue CAGR 11.6% 84/100
  • 5yr EPS CAGR -16.9% 0/100
  • Revenue-Growth Years (5) 4/5 80/100
Contributes 13.5 pts toward composite.

Cash Generation

Weight: 20%
A- 83.3
  • 5yr FCF Margin 10.8% 72/100
  • 5yr FCF/NI Conversion 0.97x 97/100
Contributes 16.7 pts toward composite.

Balance Sheet

Weight: 10%
A+ 100.0
  • Net Debt / EBITDA -1.60x 100/100
  • Interest Coverage (EBIT/Int) 45.27x 100/100
  • Altman Z-Score 6.30 100/100
Contributes 10.0 pts toward composite.

Stability

Weight: 5%
D+ 41.2
  • EPS Volatility (σ/μ) 0.75 10/100
  • Negative-Revenue Years (5) 1/5 80/100
  • Piotroski F-Score 5 56/100
Contributes 2.1 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 5 gurus held; 2 added; 2 trimmed; 1 full exit.

Holders
4 -1
Avg Δ position
-27.5%
New buys
0
Full exits
1
As of Q2 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Negative-Revenue Years (5), Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.